Jaguar Health

JAGX

Market cap $4.66M

JAGX Hedge Fund Activity: Q1 2026 in Review

10 of the 8,130 institutional investors tracked by Wall St. Rank reported a position in Jaguar Health (JAGX) for Q1 2026, worth a combined $94.2K — up 54% from $61.4K a quarter earlier.

Fund positioning in JAGX was balanced in Q1 2026: 3 funds opened new positions, 3 closed out, 3 added to existing stakes and 3 trimmed.

The largest buyer was UBS Group, adding an estimated $66.3K. The largest seller was DRW Securities, exiting entirely with an estimated $16.6K sold.

• 10 institutional investors held Jaguar Health (JAGX) as of Q1 2026, unchanged from Q4 2025.
• Funds reported $94.2K of Jaguar Health stock for Q1 2026, up 54% quarter-over-quarter.
• 3 funds opened new Jaguar Health positions in Q1 2026 and 3 closed out, a net change of 0 holders.
• The largest Jaguar Health buyer in Q1 2026 was UBS Group, an estimated $66.3K added.
• The largest Jaguar Health seller in Q1 2026 was DRW Securities, an estimated $16.6K sold.

Based on aggregated 13F filings for Q1 2026.